GRCE
Grace Therapeutics, Inc.
Grace Therapeutics, Inc. (GRCE) Stock News
The latest GRCE headlines and market coverage — 1 recent story, updated throughout the day.
- GlobeNewswire Inc.·
GRCE INVESTOR ALERT: Holzer & Holzer, LLC Investigation of Grace Therapeutics, Inc.
Law firm Holzer & Holzer is investigating whether Grace Therapeutics complied with federal securities laws following the FDA's issuance of a Complete Response Letter for its GTx-104 drug application on April 23, 2026. The CRL cited issues with packaging leachables data, non-clinical toxicology assessments, and manufacturing deficiencies, causing the company's stock price to decline. The firm is seeking investors who suffered losses to join potential litigation.